Tagged / coronavirus

Last BU paper of 2021

The scientific journal Nepal Journal of Epidemiology published its fourth and final issue of 2021 on December 31.  This issue included our systematic review ‘Epidemiologic characteristics, clinical management and Public Health Implications of Coronavirus Disease 2019 (COVID-19) in Pregnancy: A Systematic Review and meta-analysis’.  This review covered the published literature on the epidemiology, clinical management and public health prevention aspects of pregnancy and childbirth and coronavirus (COVID-19) up until December 2020.  We worked hard and fast to submit the paper as soon as possible after the end of 2020 to be able to publish up-to-date findings.  We managed this and submitted the paper on March 5th, the peer-review took some months and so did the making of the revisions.  As a result we resubmitted the manuscript of 29 September and we got the acceptance email within a week.  We made it into the next issue of the Nepal Journal of Epidemiology which published exactly one year after the data collection period had ended for our systematic review.

There are two lessons here, first even when submitting to an online journal one will experience a delay in publishing.  Secondly, the 36 papers we had appraised and included were published in 2020, meaning these scientific  papers were submitted in mid-2020 at the latest in order to make it through the peer-review process, get accepted and formatted for online publication.

In the resubmitted version we had to add as a weakness of this review that: “It is worth noting that this extensive systematic review only cover papers published in 2020, and hence studies conducted in or before 2020. This was before the emergence of variants of COVID-19, especially the delta and omicron variants.”

 

Prof. Edwin van Teijlingen

CMMPH (Centre for Midwifery, Maternal & Perinatal Health).

UK COVID-19 research passes one million participants

Please see below for an update from the National Institute for Health Research.


More than one million participants have now taken part in COVID-19 research across the UK.

NIHR data shows that a total of 1,075,000 participants have taken part in COVID-19 research, across more than 180 studies. Of these, more than 100 studies were funded by the NIHR, amounting to more than £108 million given to dedicated COVID-19 research.

This milestone has been achieved across England, Northern Ireland, Scotland and Wales by members of the public, NHS doctors and nurses, NIHR research staff and researchers, regulators, life science companies, research funders and policy makers.

Their efforts have enabled world-leading research into therapeutics such as dexamethasone and tocilizumab and delivery of the Oxford/AstraZeneca vaccine. Platform studies such as RECOVERYPRINCIPLE and REMAP-CAP have all made a significant contribution to the global understanding of COVID-19.

These discoveries have significantly improved outcomes for people who get the virus, especially those most at risk of becoming severely unwell and hospitalised.

On Monday 15 March, the NIHR and NHS will be launching the #ResearchVsCovid ‘thank you’ campaign to celebrate the efforts of participants, researchers and healthcare professionals for their involvement in COVID-19 research.

The campaign kicks off with a series of video thank yous to participants, researchers and NHS staff. These celebratory videos will feature England’s Chief Medical Officer Prof. Chris Whitty and NHS England Chief Executive, Sir Simon Stevens.

Professor Chris Whitty, Chief Medical Officer for England and co-lead for the National Institute for Health Research (NIHR), said:

“Reaching one million participants in COVID-19 research shows the impressive selflessness of people across the UK who have volunteered to take part. This research has led to vaccines, better treatments and improved care. A huge thank you to everyone who has taken part in, led or enabled the research.

NHS chief executive Sir Simon Stevens said:

“During the darkness of this pandemic, NHS clinical researchers, UK scientists and one million volunteer patients have together helped illuminate a more hopeful path for humanity.

“Thanks to their remarkable and selfless work, they have made unique and decisive contributions to therapies and vaccines for our shared global fight against Covid-19. It is amazing to consider that more than one million people in this country who have selflessly volunteered to participate in our research will themselves help save over a million lives worldwide.”

Find out more about the COVID-19 research people have helped to make happen.

https://www.nihr.ac.uk/news/uk-covid-19-research-passes-one-million-participants/27215?utm_source=twitter-research&utm_medium=social&utm_campaign=covid&utm_content=1millionnews

New interdisciplinary COVID-19 paper

An evidence-based, multidisciplinary approach on risk zoning, personal and transmission risk assessment in near real-time, and risk communication would support the optimized decisions to minimize the impact of coronavirus on our lives. This interdisciplinary paper [1], pubished today in Scientific Reports, offers a framework to assess the individual and regional risk of COVID-19 along with risk communication tools and mechanisms. Relative risk scores on a scale of 100 represent the integrated risk of influential factors. The personal risk model incorporates age, exposure history, symptoms, local risk and existing health condition, whereas regional risk is computed through the actual cases of COVID-19, public health risk factors, socioeconomic condition of the region, and immigration statistics. A web application tool (http://www.covira.info) has been developed, where anyone can assess their risk and find the guided information links primarily for Nepal. This study provides regional risk for Nepal, but the framework is scalable across the world. 

The authors comprised researchers from the University of Bristol, Science Hub (Nepal), University of the West of England, Public Health Perspective Nepal, Nepal Open University, Center for Molecular Dynamics Nepal, Mid Yorkshire Hospitals NHS Trust, the University of Huddersfield and Bournemouth University.

 

Reference:

  1. Parajuli, R.R., Mishra, B., Banstola, A. Multidisciplinary approach to COVID-19 risk communication: a framework and tool for individual and regional risk assessment. 21650 (2020). https://doi.org/10.1038/s41598-020-78779-0

NIHR Learn – Resources to support you through the Covid-19 pandemic

The NIHR Learn platform now contains a number of resources to offer guidance and support to help researchers during the pandemic.

There are resources in the following areas:

  • Understanding the science of Covid-19
  • Leading in uncertain times
  • Conveying Difficult Information to patients and relatives
  • Personal resilience
  • Wellbeing
  • Remote working
  • Online Webinars and Events

To access these you will need to create an account on the system* – if you run into any issues with creating an account  phone the helpdesk on 0207 333 5894 or email them.

Once you are on the system, click on ‘Bite-sized Learning’ from the options and then select ‘Resources to support you through the Covid-19 pandemic’.

*If you have used the system to access Good Clinical Practice training or dates you will already have an account.

External guides for managing remote research

Given current Government guidance on the pandemic response, a number of research projects will need to be conducted remotely. Below are a number of external help guides/guidance articles that aim to assist researchers with this new way of working.

The UK Data Service’s guidance on online data collection

Warwick University’s article on using Skype to collect data

Guidance on conducting telephone interviews –
Article one
Article two

The resource ‘Fieldwork during the pandemic’

The UK Research Integrity Office’s ‘Internet-mediated research’ guide

Research should remain within the ethics approval that has been granted – if you need to make any changes as a result of COVID 19 (for example moving from face-to-face to remote interviewing) please email researchethics@bournemouth.ac.uk if a member of staff or your supervisor if a student.

COVID-19 funding and research

To support the response to COVID-19 the Research Design Service South West (RDS SW) has put together a useful resource page to help researchers. This includes relevant funding calls as well as more general information about the pandemic.

Don’t forget, your local branch of the NIHR RDS is based within the BU Clinical Research Unit (BUCRU)

The BUCRU/RDS office is currently closed due to Coronavirus.  Staff are still working and able to offer research advice remotely, call us on 01202 961939 or send us an email.